How are Ketorolac Tromethamine adverse event reports trending over time?
This graph shows volume of adverse events submitted to the FDA by quarter for Ketorolac Tromethamine, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Ketorolac Tromethamine is flagged as the suspect drug causing the adverse event.
What are the most common Ketorolac Tromethamine adverse events reported to the FDA?
Renal Failure Acute | 82 (2.19%) |
Dyspnoea | 62 (1.65%) |
Nausea | 42 (1.12%) |
Medication Error | 40 (1.07%) |
Drug Ineffective | 38 (1.01%) |
Haemorrhage | 36 (.96%) |
Vision Blurred | 36 (.96%) |
Eye Pain | 35 (.93%) |
Vomiting | 34 (.91%) |
Anaphylactic Reaction | 33 (.88%) |
Ulcerative Keratitis | 33 (.88%) |
Show More |
Share/Embed Graph Export Data
This graph shows the top adverse events submitted to the FDA for Ketorolac Tromethamine, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Ketorolac Tromethamine is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.
What are the most common Ketorolac Tromethamine adverse events reported to the FDA?
Respiratory | 167 (4.45%) |
Ocular Infections, Irritations And ... | 148 (3.94%) |
Epidermal And Dermal Conditions | 143 (3.81%) |
Renal Disorders | 142 (3.78%) |
Gastrointestinal Signs | 137 (3.65%) |
Neurological | 137 (3.65%) |
Allergic Conditions | 98 (2.61%) |
Eye | 95 (2.53%) |
Vision | 92 (2.45%) |
Medication Errors | 91 (2.43%) |
Gastrointestinal Ulceration And Per... | 90 (2.4%) |
Show More |
Share/Embed Graph Export Data
This graph shows the top categories of adverse events submitted to the FDA for Ketorolac Tromethamine, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Ketorolac Tromethamine is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.
Why are people taking Ketorolac Tromethamine, according to those reporting adverse events to the FDA?
Pain | 354 |
Drug Use For Unknown Indication | 224 |
Product Used For Unknown Indication | 152 |
Back Pain | 64 |
Migraine | 59 |
Postoperative Care | 58 |
Show More |
Label | Labeler | Effective |
---|---|---|
Ketorolac Tromethamine | PD-Rx Pharmaceuticals, Inc. | 22-AUG-08 |
Ketorolac Tromethamine | Mylan Pharmaceuticals Inc. | 22-AUG-08 |
Ketorolac Tromethamine | PD-Rx Pharmaceuticals, Inc. | 22-AUG-08 |
Ketorolac Tromethamine | Akorn Inc. | 01-JUL-09 |
Ketorolac Tromethamine | Akorn Inc. | 01-AUG-09 |
Ketorolac Tromethamine | Sun Pharma Global Inc. | 29-OCT-09 |
Ketorolac Tromethamine | Apotex Corp. | 02-NOV-09 |
Ketorolac Tromethamine | Bedford Laboratories | 10-DEC-09 |
Ketorolac Tromethamine | Unit Dose Services | 20-APR-10 |
Ketorolac Tromethamine | McKesson Packaging Services Business Unit of McKesson Corporation | 03-MAY-10 |
Ketorolac Tromethamine | Baxter Healthcare Corporation | 22-JUN-10 |
Ketorolac Tromethamine | Keltman Pharmaceuticals Inc. | 21-SEP-10 |
Ketorolac Tromethamine | Rebel Distributors Corp | 29-SEP-10 |
Ketorolac Tromethamine | Rebel Distributors Corp | 29-SEP-10 |
Ketorolac Tromethamine | Falcon Pharmaceuticals, Ltd. | 06-OCT-10 |
Ketorolac Tromethamine | Falcon Pharmaceuticals, Ltd. | 06-OCT-10 |
Ketorolac Tromethamine | Lake Erie Medical DBA Quality Care Products LLC | 17-NOV-10 |
Ketorolac Tromethamine | REMEDYREPACK INC. | 06-DEC-10 |
Ketorolac Tromethamine | Rebel Distributors Corp | 17-JAN-11 |
Sprix | Physicians Total Care, Inc. | 29-JAN-11 |
Ketorolac Tromethamine | Physicians Total Care, Inc. | 17-MAR-11 |
Sprix | American Regent, Inc. | 31-MAR-11 |
Ketorolac Tromethamine | Cardinal Health | 24-MAY-11 |
Ketorolac Tromethamine | Cardinal Health | 09-JUN-11 |
Ketorolac Tromethamine | Rebel Distributors Corp | 21-SEP-11 |
Ketorolac Tromethamine | West-ward Pharmaceutical Corp. | 18-OCT-11 |
Ketorolac Tromethamine | WOCKHARDT LIMITED | 18-OCT-11 |
Ketorolac Tromethamine | H.J. Harkins Company, Inc. | 21-OCT-11 |
Ketorolac Tromethamine | WOCKHARDT USA LLC | 21-OCT-11 |
Ketorolac Tromethamine | Preferred Pharmaceuticals, Inc | 03-NOV-11 |
Acular Ls | Allergan, Inc. | 30-NOV-11 |
Ketorolac Tromethamine | STAT RX USA LLC | 30-NOV-11 |
Ketorolac Tromethamine | REMEDYREPACK INC. | 28-DEC-11 |
Ketorolac Tromethamine | Physicians Total Care, Inc. | 29-DEC-11 |
Ketorolac Tromethamine | General Injectables & Vaccines, Inc | 10-APR-12 |
Ketorolac Tromethamine | General Injectables & Vaccines, Inc | 11-APR-12 |
Acular | STAT Rx USA LLC | 31-MAY-12 |
Acular | Allergan, Inc. | 18-JUN-12 |
Ketorolac Tromethamine | Cardinal Health | 22-JUN-12 |
Ketorolac Tromethamine | Lake Erie Medical & Surgical Supply DBA Quality Care Products LLC | 03-JUL-12 |
Ketorolac Tromethamine | Pfizer Laboratories Div Pfizer Inc | 25-JUL-12 |
Ketorolac Tromethamine | Hospira, Inc. | 09-AUG-12 |
Ketorolac Tromethamine | Cardinal Health | 13-AUG-12 |
Ketorolac Tromethamine | REMEDYREPACK INC. | 04-SEP-12 |
Ketorolac Tromethamine | Bryant Ranch Prepack | 12-OCT-12 |
Sprix | H.J. Harkins Company, Inc. | 29-OCT-12 |
Acuvail | Allergan, Inc. | 15-NOV-12 |
Ketorolac Tromethamine | Hospira, Inc. | 21-NOV-12 |
Ketorolac Tromethamine | Teva Pharmaceuticals USA Inc | 03-JAN-13 |
Ketorolac Tromethamine | Fresenius Kabi USA, LLC | 31-JAN-13 |
Ketorolac Tromethamine | Physicians Total Care, Inc. | 18-FEB-13 |
Ketorolac Tromethamine | Hospira, Inc. | 19-FEB-13 |
Ketorolac Tromethamine | Hospira, Inc. | 19-FEB-13 |
Ketorolac Tromethamine | Apotex Corp. | 19-MAR-13 |
Toradol | Genentech, Inc. | 05-APR-13 |
Ketorolac Tromethamine | REMEDYREPACK INC. | 15-APR-13 |
What Ketorolac Tromethamine safety concerns are being reported by doctors and researchers in the medical literature?
This report contains aggregated drug side effects and adverse events for Ketorolac Tromethamine. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.
DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.
DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.
Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.
Share your experience with Ketorolac Tromethamine.